Position in AZN
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$401,994
New position
Shares Held
2,120
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#934
of 1,459 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HOWARD FINANCIAL SERVICES, LTD. holds $8,323,786 across 9 Drug Manufacturers - General names. AZN ranks #6 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,693 | $2,030,635 | |
| 2 | JNJ |
Johnson & Johnson
|
7,616 | $1,934,235 | |
| 3 | ABBV |
AbbVie Inc.
|
5,209 | $1,310,792 | |
| 4 | MRK |
Merck & Co., Inc.
|
8,945 | $1,149,432 | |
| 5 | AMGN |
Amgen Inc
|
2,105 | $762,262 | |
| 6 | AZN |
Astrazeneca PLC
This page
|
2,120 | $401,994 | |
| 7 | PFE |
Pfizer Inc
|
12,628 | $304,082 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
3,908 | $225,178 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $401,994 | 2,120 | Shares | Sole | 2026-07-07 | |
| No filing history on record for this holder in this stock. | ||||||